Vor Biopharma Inc (VOR)

$0.22 +0.04 (21.75%)
Market Cap 22.76M
Revenue (ttm) 0.00
Net Income (ttm) -116.91M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 2,300,300
Avg Vol 2,597,048
Day's Range N/A - N/A
Shares Out 124.96M
Stochastic %K 69%
Beta -0.51
Analysts Hold
Price Target $4.74

Company Profile

Vor Biopharma Inc. operates as a clinical-stage cell and genome engineering company. The company offers the Vor Bio platform, a technology platform for the treatment of acute myeloid leukemia (AML) and other blood cancers. It develops tremtelectogene empogeditemcel (trem-cel), a genome-edited hematopoietic stem and progenitor allogeneic donor product candidate to treat acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and other blood cancers; trem-cel in combination with Mylotarg to...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 655 6580
Address:
100 Cambridgepark Drive, Suite 101, Cambridge, United States
ChipNeo
ChipNeo Jun. 16 at 3:28 PM
$VOR tutes not scared... let's wait few months
1 · Reply
Adarali
Adarali Jun. 16 at 3:09 PM
$VOR when is the news..
0 · Reply
Adarali
Adarali Jun. 16 at 10:19 AM
$VOR anyone say me why drop..
1 · Reply
Adarali
Adarali Jun. 16 at 9:51 AM
$VOR what is happenned? Why is drop..
0 · Reply
stockmando
stockmando Jun. 16 at 4:57 AM
$VOR Found few more pictures from update-presentation. But not sure if its much important after reading conclusion haha.
2 · Reply
stockmando
stockmando Jun. 15 at 5:15 PM
$VOR VBP101
1 · Reply
stockmando
stockmando Jun. 15 at 5:14 PM
$VOR VBP101
0 · Reply
Jtlo
Jtlo Jun. 14 at 8:45 PM
$VOR i guess nothing happened
2 · Reply
stockmando
stockmando Jun. 14 at 11:18 AM
$VOR VBP301 Today, and VBP101 tomorrow.
2 · Reply
stockmando
stockmando Jun. 14 at 4:37 AM
$VOR Technically, presentation in less then 2 hours. Will see if we get any news.
0 · Reply
Latest News on VOR
Vor Bio Announces Exploration of Strategic Alternatives to Maximize Shareholder Value

May 8, 2025, 8:30 AM EDT - 5 weeks ago

Vor Bio Announces Exploration of Strategic Alternatives to Maximize Shareholder Value

Vor Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Company Update

Mar 20, 2025, 4:05 PM EDT - 3 months ago

Vor Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Company Update

Vor Bio Presents Novel Research Highlighting Opportunities and Challenges Facing Institutions Enrolling Patients in Cell and Gene Therapy Trials

Feb 13, 2025, 8:00 AM EST - 4 months ago

Vor Bio Presents Novel Research Highlighting Opportunities and Challenges Facing Institutions Enrolling Patients in Cell and Gene Therapy Trials

Vor Bio to Participate in the Oppenheimer's 35th Annual Healthcare Life Sciences Conference

Feb 3, 2025, 8:00 AM EST - 4 months ago

Vor Bio to Participate in the Oppenheimer's 35th Annual Healthcare Life Sciences Conference

Vor Bio Appoints Life Sciences and Technology Investor and Entrepreneur, Mr. Erez Kalir to its Board of Directors

Jan 8, 2025, 9:00 AM EST - 5 months ago

Vor Bio Appoints Life Sciences and Technology Investor and Entrepreneur, Mr. Erez Kalir to its Board of Directors

Vor Bio Announces $55.6 Million Private Placement

Dec 27, 2024, 9:00 AM EST - 6 months ago

Vor Bio Announces $55.6 Million Private Placement

Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design

Dec 9, 2024, 7:30 AM EST - 6 months ago

Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design

Vor Bio Appoints Seasoned Healthcare Institutional Investor, Han Choi, M.D., LL.M., as Chief Financial Officer

Sep 30, 2024, 7:00 AM EDT - 9 months ago

Vor Bio Appoints Seasoned Healthcare Institutional Investor, Han Choi, M.D., LL.M., as Chief Financial Officer

What's Going On With Penny Stock Blood Cancer-Focused Vor Biopharma On Friday?

Sep 6, 2024, 9:35 AM EDT - 10 months ago

What's Going On With Penny Stock Blood Cancer-Focused Vor Biopharma On Friday?

New Clinical Data Validates Vor Bio's Approach of Using Shielded Transplants to Deliver Targeted Therapies

Sep 5, 2024, 4:01 PM EDT - 10 months ago

New Clinical Data Validates Vor Bio's Approach of Using Shielded Transplants to Deliver Targeted Therapies

Vor Bio to Participate in Upcoming Investor Conferences

Aug 28, 2024, 8:00 AM EDT - 10 months ago

Vor Bio to Participate in Upcoming Investor Conferences

Vor Bio Reports Second Quarter 2024 Financial Results and Provides Company Update

Aug 8, 2024, 4:05 PM EDT - 11 months ago

Vor Bio Reports Second Quarter 2024 Financial Results and Provides Company Update

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Aug 2, 2024, 4:01 PM EDT - 11 months ago

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Vor Bio Reports First Quarter 2024 Financial Results and Provides Company Update

May 9, 2024, 4:05 PM EDT - 1 year ago

Vor Bio Reports First Quarter 2024 Financial Results and Provides Company Update

Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors

May 2, 2024, 4:01 PM EDT - 1 year ago

Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors

Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update

Mar 20, 2024, 4:05 PM EDT - 1 year ago

Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update

Vor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Feb 7, 2024, 8:00 AM EST - 1 year ago

Vor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate Update

Jan 17, 2024, 4:01 PM EST - 1 year ago

Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate Update

Vor Bio to Participate in the JMP Securities Hematology and Oncology Summit

Nov 27, 2023, 8:00 AM EST - 1 year ago

Vor Bio to Participate in the JMP Securities Hematology and Oncology Summit

Vor Bio Presents Positive Data Update on Trem-cel at HSCT² Conference

Nov 9, 2023, 4:01 PM EST - 1 year ago

Vor Bio Presents Positive Data Update on Trem-cel at HSCT² Conference

Vor Bio Reports Third Quarter 2023 Financial Results and Provides Company Update

Nov 7, 2023, 4:05 PM EST - 1 year ago

Vor Bio Reports Third Quarter 2023 Financial Results and Provides Company Update

Multiple Clinical and Preclinical Presentations at ASH 2023 Highlight Vor Bio's Novel eHSC and CAR-T Platform

Nov 2, 2023, 9:01 AM EDT - 1 year ago

Multiple Clinical and Preclinical Presentations at ASH 2023 Highlight Vor Bio's Novel eHSC and CAR-T Platform

Vor Bio Reports Second Quarter 2023 Financial Results and Provides Company Update

Aug 10, 2023, 4:05 PM EDT - 2 years ago

Vor Bio Reports Second Quarter 2023 Financial Results and Provides Company Update

Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference

Aug 1, 2023, 8:00 AM EDT - 2 years ago

Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference

Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In July - Cibus (NASDAQ:CBUS), Bellerophon Therapeutics (NASDAQ:BLPH)

Jul 5, 2023, 8:51 AM EDT - 2 years ago

Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In July - Cibus (NASDAQ:CBUS), Bellerophon Therapeutics (NASDAQ:BLPH)

CBUS LUCY

Successful Primary Engraftment of Trem-cel in First Five AML Patients Demonstrates Promise of Vor Bio's Platform

Jun 9, 2023, 7:30 AM EDT - 2 years ago

Successful Primary Engraftment of Trem-cel in First Five AML Patients Demonstrates Promise of Vor Bio's Platform

Vor Bio to Participate in the Goldman Sachs Healthcare Conference

Jun 5, 2023, 8:00 AM EDT - 2 years ago

Vor Bio to Participate in the Goldman Sachs Healthcare Conference

Vor Bio Reports First Quarter 2023 Financial Results and Provides Company Update

May 11, 2023, 4:05 PM EDT - 2 years ago

Vor Bio Reports First Quarter 2023 Financial Results and Provides Company Update

Vor Biopharma: Very Interesting Idea For Improving CAR-T Through Stem Cells

Mar 27, 2023, 3:13 PM EDT - 2 years ago

Vor Biopharma: Very Interesting Idea For Improving CAR-T Through Stem Cells

Vor Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Company Update

Mar 23, 2023, 4:01 PM EDT - 2 years ago

Vor Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Company Update

First AML Patient Transplanted with Vor Bio's Trem-cel Demonstrated Durable Engraftment through Multiple Mylotarg™ Cycles at Initial Dose Level

Feb 16, 2023, 12:00 PM EST - 2 years ago

First AML Patient Transplanted with Vor Bio's Trem-cel Demonstrated Durable Engraftment through Multiple Mylotarg™ Cycles at Initial Dose Level

Vor Bio to Present Clinical Data from First Patient Treated with Trem-cel at 2023 Tandem Meetings

Jan 19, 2023, 8:00 AM EST - 2 years ago

Vor Bio to Present Clinical Data from First Patient Treated with Trem-cel at 2023 Tandem Meetings

Vor Bio to Present at B. Riley Securities' 3rd Annual Oncology Conference

Jan 12, 2023, 8:00 AM EST - 2 years ago

Vor Bio to Present at B. Riley Securities' 3rd Annual Oncology Conference

Vor Bio Prices Underwritten Offering of Common Stock and Concurrent Private Placement for Aggregate Proceeds of $115.8 Million

Dec 7, 2022, 7:45 AM EST - 2 years ago

Vor Bio Prices Underwritten Offering of Common Stock and Concurrent Private Placement for Aggregate Proceeds of $115.8 Million

First AML Patient Successfully Transplanted with Vor Bio's Investigational Trem-cel (VOR33) and Tolerated Mylotarg™

Dec 7, 2022, 7:30 AM EST - 2 years ago

First AML Patient Successfully Transplanted with Vor Bio's Investigational Trem-cel (VOR33) and Tolerated Mylotarg™

Vor Bio Reports Third Quarter 2022 Financial Results and Provides Company Update

Nov 10, 2022, 4:15 PM EST - 2 years ago

Vor Bio Reports Third Quarter 2022 Financial Results and Provides Company Update

Vor Bio Appoints Eyal C. Attar, M.D.

Oct 12, 2022, 8:00 AM EDT - 2 years ago

Vor Bio Appoints Eyal C. Attar, M.D.

Vor Bio Demonstrates Potential of Base and Sequential Multiplex Editing of Hematopoietic Stem Cells for Next-generation AML Treatment

Oct 11, 2022, 8:00 AM EDT - 2 years ago

Vor Bio Demonstrates Potential of Base and Sequential Multiplex Editing of Hematopoietic Stem Cells for Next-generation AML Treatment

Vor Bio Initiates In-house Clinical Manufacturing at Cambridge, MA Headquarters

Sep 28, 2022, 8:00 AM EDT - 2 years ago

Vor Bio Initiates In-house Clinical Manufacturing at Cambridge, MA Headquarters

Vor Bio Reports Second Quarter 2022 Financial Results and Provides Company Update

Aug 11, 2022, 4:15 PM EDT - 3 years ago

Vor Bio Reports Second Quarter 2022 Financial Results and Provides Company Update

Vor Bio Successfully Demonstrates Multiplex Editing of Hematopoietic Stem Cells for Next-generation AML Treatment Presented at EHA

Jun 10, 2022, 8:00 AM EDT - 3 years ago

Vor Bio Successfully Demonstrates Multiplex Editing of Hematopoietic Stem Cells for Next-generation AML Treatment Presented at EHA

Vor Bio Reports First Quarter 2022 Financial Results and Provides Company Update

May 12, 2022, 4:15 PM EDT - 3 years ago

Vor Bio Reports First Quarter 2022 Financial Results and Provides Company Update

Vor to Participate in Two Upcoming Investor Conferences

May 5, 2022, 8:00 AM EDT - 3 years ago

Vor to Participate in Two Upcoming Investor Conferences

Vor Bio to Present at Keystone Symposia Precision Genome Engineering Meeting

Apr 25, 2022, 8:00 AM EDT - 3 years ago

Vor Bio to Present at Keystone Symposia Precision Genome Engineering Meeting

Vor Bio Announces Retirement of Chief Medical Officer

Apr 14, 2022, 4:15 PM EDT - 3 years ago

Vor Bio Announces Retirement of Chief Medical Officer

Akron BioProducts and Vor Bio to Collaborate on the Development and cGMP Manufacture of Nucleases

Mar 22, 2022, 10:10 AM EDT - 3 years ago

Akron BioProducts and Vor Bio to Collaborate on the Development and cGMP Manufacture of Nucleases

Vor Bio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Company Update

Mar 14, 2022, 4:30 PM EDT - 3 years ago

Vor Bio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Company Update

Vor to Participate in Three Upcoming Investor Conferences

Feb 28, 2022, 8:00 AM EST - 3 years ago

Vor to Participate in Three Upcoming Investor Conferences

Vor to Participate in the 11th Annual SVB Leerink Global Healthcare Conference

Feb 11, 2022, 8:00 AM EST - 3 years ago

Vor to Participate in the 11th Annual SVB Leerink Global Healthcare Conference

Vor to Participate in the JMP Securities Hematology and Oncology Summit

Nov 29, 2021, 8:00 AM EST - 3 years ago

Vor to Participate in the JMP Securities Hematology and Oncology Summit

ChipNeo
ChipNeo Jun. 16 at 3:28 PM
$VOR tutes not scared... let's wait few months
1 · Reply
Adarali
Adarali Jun. 16 at 3:09 PM
$VOR when is the news..
0 · Reply
Adarali
Adarali Jun. 16 at 10:19 AM
$VOR anyone say me why drop..
1 · Reply
Adarali
Adarali Jun. 16 at 9:51 AM
$VOR what is happenned? Why is drop..
0 · Reply
stockmando
stockmando Jun. 16 at 4:57 AM
$VOR Found few more pictures from update-presentation. But not sure if its much important after reading conclusion haha.
2 · Reply
stockmando
stockmando Jun. 15 at 5:15 PM
$VOR VBP101
1 · Reply
stockmando
stockmando Jun. 15 at 5:14 PM
$VOR VBP101
0 · Reply
Jtlo
Jtlo Jun. 14 at 8:45 PM
$VOR i guess nothing happened
2 · Reply
stockmando
stockmando Jun. 14 at 11:18 AM
$VOR VBP301 Today, and VBP101 tomorrow.
2 · Reply
stockmando
stockmando Jun. 14 at 4:37 AM
$VOR Technically, presentation in less then 2 hours. Will see if we get any news.
0 · Reply
PenkeTrading
PenkeTrading Jun. 14 at 3:30 AM
I found you an Oversold RSI (Relative Strength Index) on the daily chart of Vor Biopharma Inc. Is that bullish or bearish? $VOR #RsiOversold #NASDAQ
0 · Reply
wndyctyboy1975
wndyctyboy1975 Jun. 13 at 5:55 PM
$VOR STRAIGHT TRASH!!!
1 · Reply
Adarali
Adarali Jun. 12 at 7:59 PM
$VOR start..
0 · Reply
Adarali
Adarali Jun. 12 at 7:15 PM
$VOR must break 023 for news..
0 · Reply
Adarali
Adarali Jun. 12 at 7:01 PM
$VOR 🧐bullish..
1 · Reply
Adarali
Adarali Jun. 12 at 6:31 PM
$VOR onlu buy a lot of...
0 · Reply
Adarali
Adarali Jun. 12 at 6:30 PM
$VOR news is, coming..
0 · Reply
Adarali
Adarali Jun. 12 at 6:25 PM
$VOR What happens
0 · Reply
Adarali
Adarali Jun. 12 at 5:56 PM
$VOR 🥱
0 · Reply
Adarali
Adarali Jun. 12 at 4:10 PM
$VOR Isn t there anyone?
0 · Reply
Adarali
Adarali Jun. 12 at 2:40 PM
$VOR where are you go?
0 · Reply
Adarali
Adarali Jun. 12 at 10:46 AM
$VOR when is the news.. Today..
1 · Reply